MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In HS
… clinical study of guselkumab in patients with moderate to severe hidradenitis suppurativa or HS, a chronic skin disease also known as acne inversa.
Blog - Latest News
You are here: Home / Hidradenitis suppurativa / MorphoSys Says Janssen Initiates Phase 2 Study To Evaluate Guselkumab In...
Leave a Reply
Want to join the discussion?Feel free to contribute!